News
MCK
938.14
-2.51%
-24.19
McKesson price target raised to $1,107 from $983 at JPMorgan
TipRanks · 7h ago
Weekly Report: what happened at MCK last week (0202-0206)?
Weekly Report · 1d ago
McKesson (MCK) Is Up 12.1% After Strong Q3 EPS And Capital Moves Has The Bull Case Changed?
Simply Wall St · 1d ago
Notable healthcare headlines for the week: Pfizer Novo Nordisk in focus
Seeking Alpha · 2d ago
Assessing McKesson (MCK) Valuation After Strong Quarter, Higher Guidance And Business Portfolio Updates
Simply Wall St · 3d ago
Analysts Offer Insights on Healthcare Companies: McKesson (MCK) and Biogen (BIIB)
TipRanks · 4d ago
US Stock Market Today: S&P 500 Futures Edge Lower As Softer Jobs Data Weighed
Simply Wall St · 4d ago
Thursday Sector Leaders: Healthcare, Utilities
NASDAQ · 4d ago
Stock Index Futures Climb After Tech Rout, Amazon Slips on CapEx Blowout
Barchart · 4d ago
Trump Ally Mullin Buys 10 Stocks, Including These $5 Billion Companies You've Probably Never Heard Of
Benzinga · 4d ago
McKesson Earnings Call Highlights Specialty and Tech Strength
TipRanks · 4d ago
Stocks Settle Lower as Tech and Crypto are Routed
NASDAQ · 4d ago
McKesson Corp. Stock Rallies 16.5%, Outperforms Peers
Dow Jones · 4d ago
Software's Freefall Continues, Bitcoin Dips To 16-Month Lows: What's Moving Markets Thursday?
Benzinga · 5d ago
Mckesson Shares Climb on 3Q Revenue Boost, Raised Outlook
Dow Jones · 5d ago
Hershey Posts Upbeat Q4 Earnings, Joins FormFactor, ITT, Cardinal Health And Other Big Stocks Moving Higher On Thursday
Benzinga · 5d ago
‘Strong, Steady Performance’: McKesson Stock (MCK) Surges 16% as Wall Street Hails Q3
TipRanks · 5d ago
McKesson’s Strong Quarter Highlights Shift Toward Post Separation Focus
Simply Wall St · 5d ago
McKesson Is Maintained at Buy by TD Cowen
Dow Jones · 5d ago
TD Cowen Maintains Buy on McKesson, Raises Price Target to $1012
Benzinga · 5d ago
More
Webull provides a variety of real-time MCK stock news. You can receive the latest news about McKesson through multiple platforms. This information may help you make smarter investment decisions.
About MCK
McKesson Corporation is a diversified healthcare services company, which focuses on advancing health outcomes for patients everywhere. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products in the United States (U.S.). The Prescription Technology Solutions (RxTS) segment helps solve medication access, affordability and adherence challenges for patients by working across healthcare to connect patients, pharmacies, pharmacy benefit managers, health plans, and biopharma companies. The Medical-Surgical Solutions provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, hospital reference labs, and home healthcare agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Canada and Norway. It also offers oncology and specialty solutions.